TAX1BP3 and systemic lupus erythematosus: The therapeutic efficacy of TIP1 was evaluated in MRL/lpr mouse, a well-known model of SLE characterized with high levels of circulating antibodies and inflammatory cytokines that develop an autoimmune disease similar to human SLE [22].